WallStSmart
CURX

Curanex Pharmaceuticals Inc Common Stock

NASDAQ: CURX · HEALTHCARE · BIOTECHNOLOGY

$0.19
-2.22% today

Updated 2026-07-29

Market cap
$5.67M
P/E ratio
P/S ratio
EPS (TTM)
$-0.02
Dividend yield
52W range
$0 – $9
Volume
0.1M

WallStSmart proprietary scores

26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
9.0
Quality
A+
3.0
Profitability
D
5.0
Valuation
C+
4/9
Piotroski F-Score
Moderate
19.2
Altman Z-Score
Safe zone
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

Stock snapshot

Strengths
+ Altman Z 19.21 — safe zone
+ Debt/equity 0.04x — low leverage
Risks
- Thin margins at 0.00%
- Negative free cash flow $-954560.00

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$26000.00$0.00$0.00$0.00$0.00
Net income$-20233.00$-19198.00$-361506.00$-4.23M$-3.15M
EPS$-0.02
Free cash flow$3336.00$-120.00$-555580.00$-10.48M$-954560.00
Profit margin-77.82%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CURX$5.67M264.33.05.09.0Avoid
LLY$1.02T7610.010.04.36.0Strong Buy
JNJ$615.36B574.78.54.36.0Buy
ABBV$447.53B634.08.04.75.0-78.83%Buy
UNH$391.69B627.35.54.06.0-30.51%Buy
MRK$307.25B503.38.02.75.0-62.28%Hold

Smart narrative

Curanex Pharmaceuticals Inc Common Stock trades at $0.19. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 19.21, it sits in the safe zone.

Frequently asked questions

What is Curanex Pharmaceuticals Inc Common Stock's stock price?

Curanex Pharmaceuticals Inc Common Stock (CURX) trades at $0.19.

Is Curanex Pharmaceuticals Inc Common Stock overvalued?

Curanex Pharmaceuticals Inc Common Stock carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Curanex Pharmaceuticals Inc Common Stock's Altman Z-Score is 19.21, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-89.59%
Beta
50D MA$0.28
200D MA$0.41
Shares out0.03B
Float0.01B
Short ratio
Avg volume0.1M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years